Johnson & Johnson Will Discontinue Talc-Based Baby Powder Globally in 2023news2022-08-12T02:53:50+00:00August 12th, 2022|The New York Times|
Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suitsnews2022-07-29T17:08:24+00:00July 29th, 2022|The New York Times|
Teva Reaches Tentative $4.25 Billion Settlement Over Opioidsnews2022-07-26T22:26:32+00:00July 26th, 2022|The New York Times|
Ohio Doctor Is Acquitted of Killing Patients With Fentanylnews2022-04-20T17:15:34+00:00April 20th, 2022|The New York Times|
F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science?news2022-03-25T15:15:07+00:00March 25th, 2022|The New York Times|
Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuitsnews2022-02-25T14:12:55+00:00February 25th, 2022|The New York Times|
Tribes Reach $590 Million Opioid Settlement With Johnson & Johnsonnews2022-02-01T22:52:05+00:00February 1st, 2022|The New York Times|
Teva Pharmaceuticals Found Liable in Landmark Opioid Trialnews2021-12-30T23:06:33+00:00December 30th, 2021|The New York Times|
Judge Overturns Purdue Pharma’s Opioid Settlementnews2021-12-17T12:52:42+00:00December 17th, 2021|The New York Times|
Judge Overturns Purdue Pharma’s Opioid Settlementnews2021-12-17T12:52:42+00:00December 17th, 2021|The New York Times|
